NOX 2.94% 6.6¢ noxopharm limited

I believe they will have to, while it is just a designation...

  1. 17 Posts.
    lightbulb Created with Sketch. 6
    I believe they will have to, while it is just a designation there are some potential benefits:
    (from the FDA website)
    Orphan drug designation qualifies sponsors for incentives including: Tax credits for qualified clinical trials, Exemption from user fees, Potential seven years of market exclusivity after approval
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.6¢
Change
-0.002(2.94%)
Mkt cap ! $19.28M
Open High Low Value Volume
6.7¢ 6.9¢ 6.6¢ $13.31K 198.1K

Buyers (Bids)

No. Vol. Price($)
1 1137 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 22400 1
View Market Depth
Last trade - 15.50pm 28/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.